Kuros Biosciences AG (id:13176 KURN)
20.20 CHF
Opening hours: 09:00 - 17:20 (Central European Standard Time: 12/24/2024 5:12:58 PM)
Exchange open, closes in 6 minutes
About Kuros Biosciences AG
Market Capitalization 755.22M
Kuros Biosciences AG, a biopharmaceutical company, engages in the commercialization and development for tissue repair and bone regeneration in the United States, the European Union, and internationally. It operates through three segments: Medical Devices, Pharmaceuticals, and Legacy Portfolio. The company offers MagnetOs Granules, an original advanced bone graft based on the submicron needle-shaped NeedleGrip surface technology; MagnetOs Putty, a mold use to fill bony voids for a predictable fusion; MagnetOs Easypack Putty, a ready-to-use mold to be implanted in any intervertebral disc space or posterolateral spine level; and Magnetos Flex Matrix, an open matrix bone graft. Its Fibrin-PTH pipeline products comprise KUR-111 and KUR-113 that are in Phase 2b clinical trials for trauma indications; KUR-113 that is in Phase 2a clinical trial for spinal indications. The company was incorporated in 2016 and is headquartered in Schlieren, Switzerland.
| Headquarters (address) |
Wagistrasse 25 Schlieren 8952 Switzerland |
| Phone | 41 44 733 4747 |
| Website | https://www.kuros.ch |
| Employees | 106 |
| Sector | Healthcare |
| Industry | Medical Devices |
| Ticker | KURN |
| Exchange | Swiss Stock Exchange |
| Currency | CHF |
| 52 week range | 3.06 - 32.00 |
| Market Capitalization | 755.22M |
| P/E trailing | -53.16 |
| Price/Sale | 14.37 |
| Price/Book | 7.05 |
| Beta | 3.00 |
| EPS | 3.00 |
| EPS Switzerland (ID:153, base:188) | 28.46 |